Home / Sertraline / Czechia
CZ ATC N06AB06 · updated 2 Nov 2026
Sertraline shortage in Czechia
Is there a Sertraline shortage in Czechia?
Yes. As of 2 Nov 2026, 9 Sertraline products are reported short in Czechia, the first since 25 Jul 2024. The company estimate for the return is 20 Nov 2026 (latest 28 Feb 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, Italy, Spain, Ireland, Austria, Belgium, Sweden, Japan, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | SERTRALIN MYLAN 100MG 100MG TBL FLM 30 | VIATRIS LIMITED, Dublin | 25 Jul 2024 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | SERTRALIN MYLAN 50MG 50MG TBL FLM 90 | VIATRIS LIMITED, Dublin | 1 Nov 2024 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | SERTRALIN MYLAN 50MG 50MG TBL FLM 30 | VIATRIS LIMITED, Dublin | 1 May 2025 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | SERTIVAN 50MG 50MG TBL FLM 98 | Hexal AG, Holzkirchen | 12 May 2026 | 4 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | SERTIVAN 100MG 100MG TBL FLM 30 | Hexal AG, Holzkirchen | 22 Sep 2026 | 20 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | SERTIVAN 50MG 50MG TBL FLM 100 | Hexal AG, Holzkirchen | 22 Sep 2026 | 20 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | SERTIVAN 50MG 50MG TBL FLM 30 | Hexal AG, Holzkirchen | 22 Sep 2026 | 20 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | SERTRALIN ACTAVIS 50MG 50MG TBL FLM 30 | Teva B.V., Haarlem | 7 Oct 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | SERTRALIN ACTAVIS 100MG 100MG TBL FLM 30 anticipated | Teva B.V., Haarlem | 5 Dec 2026 | 28 Feb 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.